DOI
10.1186/s13020-021-00558-4
Acupuncture for cancer pain: an evidence-based clinical practice guideline
作者地址
Department of Social Medicine and Health Management, School of Public Health, Lanzhou University, Lanzhou, China
通讯作者
Guo X; Xue CC; Zhang H
摘要
Background:This study aims to develop an evidence-based clinical practice guideline of acupuncture in the treatment of patients with moderate and severe cancer pain.
Methods:The development of this guideline was triggered by a systematic review published in JAMA Oncology in 2020. We searched databases and websites for evidence on patient preferences and values, and other resources of using acupuncture for treatment of cancer pain. Recommendations were developed through a Delphi consensus of an international multidisciplinary panel including 13 western medicine oncologists, Chinese medicine/acupuncture clinical practitioners, and two patient representatives. The certainty of evidence, patient preferences and values, resources, and other factors were fully considered in formulating the recommendations. The Grading of Recommendations Assessment, Development, and Evaluation (GRADE) approach was employed to rate the certainty of evidence and the strength of recommendations.
Results:The guideline proposed three recommendations: (1) a strong recommendation for the treatment of acupuncture rather than no treatment to relieve pain in patients with moderate to severe cancer pain; (2) a weak recommendation for the combination treatments with acupuncture/acupressure to reduce pain intensity, decrease the opioid dose, and alleviate opioid-related side effects in moderate to severe cancer pain patients who are using analgesics; and (3) a strong recommendation for acupuncture in breast cancer patients to relieve their aromatase inhibitor-induced arthralgia.
Conclusion:This proposed guideline provides recommendations for the management of patients with cancer pain. The small sample sizes of evidence limit the strength of the recommendations and highlights the need for additional research.
资助信息
This guideline was funded by the National Key R&D Program, China National Centre for Biotechnology Development (No. 2019YFC1709805)
资助机构
China National Centre for Biotechnology Development
WOS学科分类
Integrative & Complementary MedicinePharmacology & Pharmacy
WOS关键词
BREAST-CANCERINTEGRATIVE ONCOLOGYHEALTH-CAREMANAGEMENTELECTROACUPUNCTURECOMPLEMENTARYTRIALWOMEN
附件
-
95 Acupuncture for cancer pain an evidence-based clinical practice guideline.pdf
2.63 MB
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
